ROCHESTER, N.Y. and BOSTON, Sept. 10, 2013 (GLOBE NEWSWIRE) -- Caliber Imaging & Diagnostics (Caliber I.D.), formerly Lucid, Inc. (LCDX), has introduced the VivaScope® 1500 Multilaser system, the newest device in the company's VivaScope confocal microscope product line. VivaScope Multilaser cellular imaging devices give researchers the option of a painless, noninvasive optical skin biopsy to study changes at the cellular level.
The new VivaScope 1500 Multilaser systems include three lasers of different wavelengths that can be used in fluorescence-mode imaging to enhance image contrast when combined with dyes that are FDA-approved for human use. The system is well suited for a wide variety of skin research applications for the evaluation of personal care products, pharmaceuticals and in animal research. With the VivaScope 1500 Multilaser system, changes in living skin are viewed at the cellular level, and because the imaging is completely noninvasive, cellular changes can be monitored over time without damage to the tissue.
L. Michael Hone, Chief Executive Officer of Caliber I.D., said, "The VivaScope 1500 Multilaser system gives researchers a powerful new tool for performing cellular level analysis painlessly and noninvasively. The inclusion of lasers at three different wavelengths within a single system offers an unprecedented level of flexibility to researchers studying a variety of products, drugs and diseases. We believe this is an extremely important addition to our existing range of VivaScope devices."
For more details about the VivaScope 1500 Multilaser system, please click here.
About Caliber Imaging & Diagnostics
Caliber Imaging & Diagnostics' platform of products offer increased productivity from the research laboratory to the doctor's office or the surgeon's operating room. Caliber I.D.'s platform of products provide precise accuracy, consistent reliability, and online backup that all combine to lead to better patient care. For more information about Caliber I.D. and its products, please visit www.caliberid.com.
VivaScope® is a registered trademark of Caliber Imaging & Diagnostics.
This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes," "assumes" and variations of such words or similar expressions that predict or indicate future events or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the Forms 10-Q and 10-K filed by us with the Securities and Exchange Commission.
CONTACT: Richard Pulsifer Chief Financial Officer (617) 348-9821 Investor Relations: Dian Griesel Inc. Cheryl Schneider (212) 825-3210 email@example.com Public Relations: Dian Griesel Inc. Susan Forman or Laura Radocaj (212) 825-3210 firstname.lastname@example.org email@example.comSource:Caliber Imaging & Diagnostics, Inc.